Intelligent Bio Solutions (INBS) Competitors $1.90 -0.08 (-4.04%) As of 06/12/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock INBS vs. ECOR, POCI, NEPH, TMDIF, COCH, DRIO, PYPD, NMTC, BDMD, and LYRAShould you be buying Intelligent Bio Solutions stock or one of its competitors? The main competitors of Intelligent Bio Solutions include electroCore (ECOR), Precision Optics (POCI), Nephros (NEPH), Titan Medical (TMDIF), Envoy Medical (COCH), DarioHealth (DRIO), PolyPid (PYPD), NeuroOne Medical Technologies (NMTC), Baird Medical Investment (BDMD), and Lyra Therapeutics (LYRA). These companies are all part of the "medical equipment" industry. Intelligent Bio Solutions vs. Its Competitors electroCore Precision Optics Nephros Titan Medical Envoy Medical DarioHealth PolyPid NeuroOne Medical Technologies Baird Medical Investment Lyra Therapeutics Intelligent Bio Solutions (NASDAQ:INBS) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations. Which has better earnings and valuation, INBS or ECOR? Intelligent Bio Solutions has higher earnings, but lower revenue than electroCore. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIntelligent Bio Solutions$2.94M4.47-$10.16MN/AN/AelectroCore$26.46M1.51-$18.83M-$1.56-3.44 Do analysts recommend INBS or ECOR? electroCore has a consensus price target of $25.50, suggesting a potential upside of 374.86%. Given electroCore's stronger consensus rating and higher possible upside, analysts clearly believe electroCore is more favorable than Intelligent Bio Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Bio Solutions 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00electroCore 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer INBS or ECOR? In the previous week, Intelligent Bio Solutions had 4 more articles in the media than electroCore. MarketBeat recorded 5 mentions for Intelligent Bio Solutions and 1 mentions for electroCore. electroCore's average media sentiment score of 1.87 beat Intelligent Bio Solutions' score of 1.01 indicating that electroCore is being referred to more favorably in the news media. Company Overall Sentiment Intelligent Bio Solutions Positive electroCore Very Positive Is INBS or ECOR more profitable? electroCore has a net margin of -54.40% compared to Intelligent Bio Solutions' net margin of -323.79%. Intelligent Bio Solutions' return on equity of -146.03% beat electroCore's return on equity.Company Net Margins Return on Equity Return on Assets Intelligent Bio Solutions-323.79% -146.03% -83.62% electroCore -54.40%-154.45%-69.16% Do institutionals and insiders believe in INBS or ECOR? 33.0% of Intelligent Bio Solutions shares are held by institutional investors. Comparatively, 26.7% of electroCore shares are held by institutional investors. 1.5% of Intelligent Bio Solutions shares are held by company insiders. Comparatively, 19.7% of electroCore shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community favor INBS or ECOR? electroCore received 167 more outperform votes than Intelligent Bio Solutions when rated by MarketBeat users. Likewise, 62.55% of users gave electroCore an outperform vote while only 0.00% of users gave Intelligent Bio Solutions an outperform vote. CompanyUnderperformOutperformIntelligent Bio SolutionsOutperform VotesNo VotesUnderperform Votes1100.00% electroCoreOutperform Votes16762.55% Underperform Votes10037.45% Which has more risk and volatility, INBS or ECOR? Intelligent Bio Solutions has a beta of 4.58, indicating that its share price is 358% more volatile than the S&P 500. Comparatively, electroCore has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500. SummaryelectroCore beats Intelligent Bio Solutions on 10 of the 16 factors compared between the two stocks. Get Intelligent Bio Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for INBS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INBS vs. The Competition Export to ExcelMetricIntelligent Bio SolutionsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.13M$4.37B$5.61B$8.62BDividend YieldN/A42.67%5.28%4.17%P/E RatioN/A28.2927.1419.96Price / Sales4.4770.02416.49157.63Price / CashN/A51.0838.2534.64Price / Book2.385.827.074.69Net Income-$10.16M$67.63M$3.23B$248.14M7 Day Performance14.46%-1.03%0.72%0.91%1 Month Performance39.71%16.63%9.65%5.71%1 Year Performance-12.04%18.79%32.02%14.71% Intelligent Bio Solutions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INBSIntelligent Bio Solutions0.4886 of 5 stars$1.90-4.0%N/A-15.2%$13.13M$2.94M0.0010Positive NewsECORelectroCore2.8484 of 5 stars$5.01+0.2%$25.50+409.0%-17.5%$37.10M$26.46M-2.7450POCIPrecision Optics0.3147 of 5 stars$4.66+7.8%N/A-22.3%$35.69M$17.63M-7.2780Short Interest ↑NEPHNephros1.1868 of 5 stars$3.13+15.1%$5.00+59.7%+84.8%$33.18M$15.52M-34.7830Short Interest ↑High Trading VolumeTMDIFTitan MedicalN/A$0.29-0.2%N/A+558.2%$32.73M$17.63M-0.2350COCHEnvoy Medical2.3375 of 5 stars$1.50-1.4%$9.25+516.7%-42.9%$31.99M$212K-1.0934Positive NewsShort Interest ↑DRIODarioHealth1.7184 of 5 stars$0.70-2.1%$2.00+185.7%-39.3%$31.13M$28.03M-0.74200PYPDPolyPid3.1567 of 5 stars$2.95+5.4%$11.33+284.2%-23.3%$30.06MN/A-0.5980Trending NewsAnalyst RevisionHigh Trading VolumeNMTCNeuroOne Medical Technologies2.3907 of 5 stars$0.59-3.0%$1.45+144.6%-36.5%$29.54M$5.76M-2.2820Positive NewsGap UpHigh Trading VolumeBDMDBaird Medical InvestmentN/A$4.41+14.5%N/AN/A$29.04M$37.04M0.00N/AGap DownLYRALyra Therapeutics3.0822 of 5 stars$20.25+310.8%$100.00+393.8%-23.5%$26.83M$1.19M-13.5950Positive NewsShort Interest ↓Analyst RevisionHigh Trading Volume Related Companies and Tools Related Companies ECOR Competitors POCI Competitors NEPH Competitors TMDIF Competitors COCH Competitors DRIO Competitors PYPD Competitors NMTC Competitors BDMD Competitors LYRA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INBS) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intelligent Bio Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intelligent Bio Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INBS Stock Free INBS Stock Alerts